全文获取类型
收费全文 | 1030篇 |
免费 | 42篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 14篇 |
儿科学 | 38篇 |
妇产科学 | 57篇 |
基础医学 | 94篇 |
口腔科学 | 20篇 |
临床医学 | 91篇 |
内科学 | 195篇 |
皮肤病学 | 11篇 |
神经病学 | 33篇 |
特种医学 | 248篇 |
外科学 | 67篇 |
综合类 | 20篇 |
预防医学 | 55篇 |
眼科学 | 17篇 |
药学 | 56篇 |
1篇 | |
中国医学 | 14篇 |
肿瘤学 | 44篇 |
出版年
2022年 | 4篇 |
2021年 | 10篇 |
2019年 | 7篇 |
2018年 | 12篇 |
2017年 | 14篇 |
2016年 | 12篇 |
2015年 | 20篇 |
2014年 | 21篇 |
2013年 | 26篇 |
2012年 | 28篇 |
2011年 | 44篇 |
2010年 | 29篇 |
2009年 | 34篇 |
2008年 | 31篇 |
2007年 | 35篇 |
2006年 | 39篇 |
2005年 | 22篇 |
2004年 | 7篇 |
2003年 | 18篇 |
2002年 | 13篇 |
2001年 | 6篇 |
2000年 | 19篇 |
1999年 | 9篇 |
1998年 | 37篇 |
1997年 | 34篇 |
1996年 | 39篇 |
1995年 | 48篇 |
1994年 | 39篇 |
1993年 | 39篇 |
1992年 | 9篇 |
1991年 | 10篇 |
1990年 | 22篇 |
1989年 | 40篇 |
1988年 | 26篇 |
1987年 | 34篇 |
1986年 | 40篇 |
1985年 | 23篇 |
1984年 | 19篇 |
1983年 | 16篇 |
1982年 | 15篇 |
1981年 | 19篇 |
1980年 | 18篇 |
1979年 | 9篇 |
1978年 | 15篇 |
1977年 | 17篇 |
1976年 | 13篇 |
1975年 | 12篇 |
1958年 | 4篇 |
1957年 | 6篇 |
1954年 | 2篇 |
排序方式: 共有1075条查询结果,搜索用时 15 毫秒
81.
ALADAR RONASZEKI HUGO ECTOR BOUDEWIJN DENEF RE E. AUBERT VAN DE WERF HILAIRE DE GEEST 《Pacing and clinical electrophysiology : PACE》1990,13(12):1728-1731
RONASZEKI, A., ET AL.: Effect of Short Atrioventricular Delay on Cardiac Output. Short atrioventricular (AV) delay modifies late diastolic filling dynamics. The effect of this change on cardiac output [CO) was studied in closed chest, AV blocked canine preparations (N: 10), during AV sequential pacing (80 bpm). CO (thermodilution technique) and transmitral flow velocity (TMFV, pulsed-wave Doppler) were measured and compared (paired t-test) on the basis of TMFV pattern, when atrial contraction (A wave) started just after early diastolic transmitral flow deceleration [PR:219 ± 25 ms, mean ± SD) and when A wave occurred at the end of late diastole and shortened due to the next ventricular contraction (PR: 56 ± 11 ms). The short AV delay resulted in 12.0 ± 5.9% decrease of CO, reflecting the interrupted late diastolic atrial transport. Properly timed atrial contraction is necessary for optimal AV sequential pacing. 相似文献
82.
Coxon RE; Fekade D; Knox K; Hussein K; Melka A; Daniel A; Griffin GG; Warrell DA 《QJM : monthly journal of the Association of Physicians》1997,90(3):213-221
Severe Jarisch Herxheimer reaction (J-HR) precipitated by antibiotic
treatment of louse-borne relapsing fever (LBRF) is associated with a
transient, marked rise in circulating tumour necrosis factor alpha (TNF
alpha), interleukin 6 (IL-6) and interleukin 8 (IL-8). Ovine polyclonal
anti-TNF alpha antibody fragments (Fab) were used in a randomized double
blind placebo controlled trial in an attempt to prevent this reaction.
Within 4 h after penicillin, in controls (n = 29), a several- fold rise in
cytokines occurred, concomitant with a fall in spirochaetes and maximal
clinical manifestations of the J-HR. An intravenous infusion of anti-TNF
alpha Fab, 30 min before penicillin in 20 patients reduced peak plasma
levels of IL-6 and IL-8 (but not IL-1 beta) compared with controls (p =
0.01 and < 0.001, respectively) and the incidence of the J-HR,
indicating some neutralization of TNF alpha. An apparent fall in TNF alpha
reflected interference of anti-TNF alpha in the immunoassay.
相似文献
83.
84.
卒中是一种常见、严重的疾病,仅美国每年的新发病例就高达795000例,并已成为全世界人类死亡和残疾的主要病因。10年前,重组型组织纤溶酶原激活剂(recombinant tissue plasminogen activator,rt—PA)被批准用于治疗急性缺血性卒中。rt—PA应用指南建议,应在卒中发病后3h内静脉给予rt—PA,给药前应行头部CT检查,排除颅内出血。 相似文献
85.
急性缺血性卒中影像学检查的建议——美国心脏协会的科学声明(中) 总被引:1,自引:0,他引:1
2.3核磁共振血管成像(MRA)
2.3.1背景和方法:在头部MRI检查中常结合MRA,用于急性卒中患者病情评估以指导治疗决策的制定^[19]。日前,有几种不同的MRA技术用于脑血管成像,包括二维时间飞跃(timeof-flight,TOF)序列、三维TOF序列、 相似文献
86.
急性失代偿性心力衰竭患者血清肌钙蛋白T水平检测的价值 总被引:1,自引:0,他引:1
目的:研究肌钙蛋白T的水平变化在急性失代偿性心力衰竭患者预后的价值。方法:选取急诊重症监护室收治的68例急性失代偿性心力衰竭患者,按照cTnT的水平分为cTnT阳性组(27例)和cTnT阴性组(41例)。观察两组患者室性期前收缩发生率、APACHEⅡ评分、在ICU入住时间、住院时间、住院病死率、随访出院后6个月内再入院率及6个月死亡率。结果:两组治疗期间利尿剂、扩血管药物使用、多巴胺和(或)多巴酚丁胺的使用和两组患者6个月随访期间死亡率比较差异无统计学意义(P〉0.05)。入院时APACHEⅡ评分、在ICU入住时间、住院时间、住院病死率及出院后6个月内再入院率比较均显示差异有统计学意义(P〈0.05)。结论:肌钙蛋白T水平是与治疗无关的危险因素之一。伴有肌钙蛋白T升高的急性失代偿性心力衰竭患者有较高的室性期前收缩发生率、较长的住院时间、短期预后差,监测cTnT水平对急性失代偿性心力衰竭患者的病情评估和短期预后有重要作用。 相似文献
87.
88.
89.
Major complications after 400 continuous popliteal sciatic nerve blocks for post‐operative analgesia
V. COMPÈRE N. REY O. BAERT A. OUENNICH V. FOURDRINIER X. ROUSSIGNOL R. BECCARI B. DUREUIL 《Acta anaesthesiologica Scandinavica》2009,53(3):339-345
Background: A continuous popliteal sciatic nerve block (CPSNB) has been performed with increasing frequency for post‐operative analgesia after foot surgery. Major complications associated with the placement of a perineural catheter remain rarely studied. The aim of this study was to prospectively determine the incidence of major complications (neurological and infectious) in post‐operative adult patients with a continuous popliteal catheter inserted by the anatomical posterior approach for analgesia after foot surgery. Methods: All popliteal catheters were placed pre‐operatively under sterile conditions with the aid of a nerve stimulator technique. The primary outcome measure was the incidence of major complications including infection and neuropathy. As a secondary outcome, adverse effects as well as other complications were also evaluated. Data were expressed as median [25th–75th percentiles]. Results: A total of 400 patients were included in the study during a 2‐year period. The median time the catheter remained indwelling was 47 h [23, 54]. Major complications included three events (0.75%) with one infection (0.25%) and two neuropathies (0.50%). Three blocks were unsuccessful and the catheter insertion was difficult in 12 patients (3%). During the CPSNB procedure, one patient reported slight paraesthesia during stimulation. Patient satisfaction was scored at 4 for 89%, 3 for 6% and 2 for 5% on the analogue scale. Conclusions: Major complications after the use of CPSN are not in fact rare. The incidence of severe neuropathy or infection complications is, respectively, 0.50% and 0.25%. However, the insertion of CPSN could be considered effective and is associated with only a few minor complications. 相似文献
90.
BACKGROUND/AIMS: To evaluate the effectiveness of a single administration of intravenous octreotide infusion in preventing post-ERCP pancreatitis and progressing hyperamylasemia. METHODOLOGY: One hundred and twenty (71 female, 59 male) patients who had been diagnosed with pancreaticobiliary pathology were included in this study. 100 microgram (0.1 mg) octreotide diluted in 60 mL normal saline solution administered intravenously 60 minutes prior to the procedure and continued during the procedure and after the procedure. Placebo was given in 87 patients. Patients were assessed clinically and serum amylase level was also measured before the procedure and 3, 12, and 24 hours after the procedure. We define clinical pancreatitis as serum amylase level greater than 4-5 times in conjunction with clinical assessment. RESULTS: Hyperamylasemia was assessed in 14 of 33 (42.4%) administered octreotide patients. Clinical findings of pancreatitis were observed in 5 of these 14 (11.5%) patients. Hyperamylasemia was also assessed in 41 of 87 (47.1%) administered placebo patients. Clinical findings of pancreatitis were observed in 10 of these 41 (11.5) patients. There were no significant differences between the groups, statistically (p > 0.05) (Pearson chi-square test). CONCLUSIONS: The results of this trial indicate that a single administration of intravenous octreotide infusion does not prevent ERCP-induced pancreatitis and effect serum amylase level. 相似文献